OCSE:CHR (Denmark)
Business Description
Chr. Hansen Holding A/S
NAICS : 325998
Boge Alle 10-12, Horsholm, DNK, 2970
Compare
Compare
Traded in other countries / regions
CHR.Denmark
•
51C.Germany
•
CHR.Mexico
•
0MR6.UK
•
CHYHY.USA
Description
Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company with more than 3,200 employees across 30 countries. Its segments include food cultures and enzymes that produce and sell innovative cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf-life, nutritional value, and health benefits of a variety of consumer products in the food industry, especially in the dairy industry; and health and nutrition that produce and sell products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.06 | |||||
| Equity-to-Asset | 0.54 | |||||
| Debt-to-Equity | 0.56 | |||||
| Debt-to-EBITDA | 3.14 | |||||
| Interest Coverage | 17.51 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.68 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EBITDA Growth Rate | -0.1 | |||||
| 3-Year EPS without NRI Growth Rate | -4.5 | |||||
| 3-Year FCF Growth Rate | -7.4 | |||||
| 3-Year Book Growth Rate | 28.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Industry Rank | 9.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 9.65 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.12 | |||||
| 9-Day RSI | 38.9 | |||||
| 14-Day RSI | 40.1 | |||||
| 6-1 Month Momentum % | 0.85 | |||||
| 12-1 Month Momentum % | -16.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.31 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 102.87 | |||||
| Days Sales Outstanding | 53.92 | |||||
| Days Payable | 72.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.44 | |||||
| Dividend Payout Ratio | 0.5 | |||||
| 3-Year Dividend Growth Rate | -100 | |||||
| Forward Dividend Yield % | 1.44 | |||||
| 5-Year Yield-on-Cost % | 1.44 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.94 | |||||
| Operating Margin % | 26.92 | |||||
| Net Margin % | 19.62 | |||||
| ROE % | 14.3 | |||||
| ROA % | 7.42 | |||||
| ROIC % | 8.82 | |||||
| ROC (Joel Greenblatt) % | 34.44 | |||||
| ROCE % | 11.42 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.48 | |||||
| Forward PE Ratio | 30.3 | |||||
| PE Ratio without NRI | 34.71 | |||||
| Shiller PE Ratio | 28.04 | |||||
| Price-to-Owner-Earnings | 62 | |||||
| PEG Ratio | 9.38 | |||||
| PS Ratio | 6.78 | |||||
| PB Ratio | 4.55 | |||||
| Price-to-Free-Cash-Flow | 42.04 | |||||
| Price-to-Operating-Cash-Flow | 24.55 | |||||
| EV-to-EBIT | 28.96 | |||||
| EV-to-Forward-EBIT | 24.48 | |||||
| EV-to-EBITDA | 28.96 | |||||
| EV-to-Forward-EBITDA | 18.57 | |||||
| EV-to-Revenue | 7.55 | |||||
| EV-to-Forward-Revenue | 6.76 | |||||
| EV-to-FCF | 46.58 | |||||
| Price-to-Projected-FCF | 2.48 | |||||
| Price-to-DCF (Earnings Based) | 2.15 | |||||
| Price-to-DCF (FCF Based) | 2.68 | |||||
| Price-to-Median-PS-Value | 0.83 | |||||
| Earnings Yield (Greenblatt) % | 3.46 | |||||
| Forward Rate of Return (Yacktman) % | 1.69 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 8,805.125 | ||
| EPS (TTM) (kr) | 13.169 | ||
| Beta | 0.41 | ||
| Volatility % | 22.21 | ||
| 14-Day RSI | 40.1 | ||
| 14-Day ATR (kr) | 12.68745 | ||
| 20-Day SMA (kr) | 461 | ||
| 12-1 Month Momentum % | -16.96 | ||
| 52-Week Range (kr) | 443.4 - 591.8 | ||
| Shares Outstanding (Mil) | 131.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chr. Hansen Holding A/S Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||